Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.46% slumped 0.89% to $173.94 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +3.06% falling 0.58% to 3,900.79 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +2.68% falling 0.75% to 31,253.13. This was the stock's second consecutive day of losses. Johnson & Johnson closed $12.75 short of its 52-week high ($186.69), which the company reached on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +3.63% fell 2.04% to $316.01, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.23% fell 0.01% to $92.09, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +2.99% rose 0.50% to $50.65. Trading volume (6.8 M) remained 833,049 below its 50-day average volume of 7.6 M.